FidoCure®
FidoCure® is the leader in Precision Medicine for Canine Oncology.
Based based in San Francisco, CA, USA; Palo Alto, CA, USA; Remote, FidoCure® works in healthcare.
Profile
Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine.
FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics.
Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US.
Together, we can combat canine cancer!
Within the healthcare space, the company focuses on its core offering rather than a broad product line.
The business is associated with San Francisco, CA, USA; Palo Alto, CA, USA; Remote.
It is recorded at the Winter 2018 stage.
Recorded headcount: 14 employees.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA; Palo Alto, CA, USA; Remote |
| Country | USA; Remote |
| Employees | 14 |
| Stage | Winter 2018 |
Website: www.fidocure.com
Browse related
Create a free account